DYMISTA DUACTIVE Trademark

Trademark Overview

On Thursday, March 25, 2021, a trademark application was filed for DYMISTA DUACTIVE with the United States Patent and Trademark Office. The USPTO has given the DYMISTA DUACTIVE trademark a serial number of 90603178. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, December 15, 2023. This trademark is owned by Meda Pharmaceuticals Inc.. The DYMISTA DUACTIVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals for the treatment of allergies
dymista duactive

General Information

Serial Number90603178
Word MarkDYMISTA DUACTIVE
Filing DateThursday, March 25, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, December 15, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, October 26, 2021

Trademark Statements

Description of MarkThe mark consists of the stylized wording "DYMISTA" in navy above the wording "DUACTIVE" in light blue. An upside down check mark shape in navy appears above the letters "DY" and a check mark shape in light blue appears below the letters "DY".
Goods and ServicesPharmaceuticals for the treatment of allergies
Indication of Colors claimedThe color(s) Navy and Light Blue is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 1, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMeda Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCanonsburg, PA 15317
Party NameMeda Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCanonsburg, PA 15317

Trademark Events

Event DateEvent Description
Tuesday, December 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 15, 2023SOU EXTENSION 4 GRANTED
Friday, December 15, 2023SOU EXTENSION 4 FILED
Friday, December 15, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, June 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 2, 2023SOU EXTENSION 3 GRANTED
Friday, June 2, 2023SOU EXTENSION 3 FILED
Friday, June 2, 2023SOU TEAS EXTENSION RECEIVED
Saturday, December 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 15, 2022SOU EXTENSION 2 GRANTED
Thursday, December 15, 2022SOU EXTENSION 2 FILED
Thursday, December 15, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 14, 2022SOU EXTENSION 1 GRANTED
Tuesday, June 14, 2022SOU EXTENSION 1 FILED
Tuesday, June 14, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 21, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 26, 2021PUBLISHED FOR OPPOSITION
Wednesday, October 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 14, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 14, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 14, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 13, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 13, 2021NON-FINAL ACTION E-MAILED
Monday, September 13, 2021NON-FINAL ACTION WRITTEN
Tuesday, September 7, 2021ASSIGNED TO EXAMINER
Friday, July 2, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, July 1, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 29, 2021NEW APPLICATION ENTERED

Related Keywords

duactive dymista allergies treatment pharmaceuticals